The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy

American Journal of Surgery

Volumn 179, Issue 6, 2000, Pages 446-452

  Vlastos, Georges ^a   Fornage, Bruno D ^a   Mirza, Nadeem Q ^a   Bedi, Depak ^a   Lenert, Jeffrey T ^a   Winchester, David J ^b   Tolley, Susanne M ^a   Ames, Fred C ^a   Ross, Merrick I ^a   Feig, Barry W ^a   Hunt, Kelly K ^a   Buzdar, Aman U ^a   Singletary, S Eva ^a  

^a NQM JTL SMT FCA MIR BWF K   (United States)

^b EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; DOXORUBICIN; FLUOROURACIL; RANITIDINE; TAXOL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BIOPSY, NEEDLE; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMAN; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGE; NEOPLASM STAGING; PACLITAXEL; PHYSICAL EXAMINATION; PREMEDICATION; PROSPECTIVE STUDIES; RANITIDINE; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY;

EID: 0033795199     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00382-2     Document Type: Article

References (44)

1. Fisher B., Bauer M., Wickerham D.L., et al. Relation of the number of positive axillary nodes to the prognosis of patients with primary breast cancer, an NSABP update. Cancer. 52:1983;1551-1557.
2. Calle R., Pilleron J.P., Schlienger P., Vilcoq J.R. Conservative management of operable breast cancer ten years experience at the Foundation Curie . Cancer. 42:1978;2045-2053.
3. Maunsell E., Brisson J., Deshenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 36:1993;315-329.
4. Hladiuk M., Huchcroft S., Temple W., Schnurr B.E. Arm function after axillary dissection for breast cancer a pilot study to provide parameter estimates . J Surg Oncol. 50:1992;47-52.
5. Wallace I.W.J., Champion H.R. Axillary nodes in breast cancer. Lancet. 1:1972;692.
6. Kalisher L. Xero-radiography of axillary lymph nodes disease. Radiology. 115:1975;67-71.
7. Kendall B.E., Arthur J.F., Patey D.H. Lymphangiography in carcinoma of the breast. A comparison of clinical, radiological and pathological findings in axillary lymph nodes. Cancer. 16:1963;1233-1242.
8. Ege G.N. Internal mammary lymphoscintigraphy a rational adjunct to the staging and management of breast carcinoma . Clin Radiol. 29:1978;453-456.
9. Bourgeois P., Fruhling J., Henry J. Postoperative axillary lymphoscintigraphy in the management of breast cancer. Int J Radiat Oncol Biol Phys. 9:1983;29-32.
10. Bruneton J.N., Caramella E., Hery M., et al. Axillary lymph node metastases in breast cancer preoperative detection with ultrasound . Radiology. 158:1986;325-326.
11. Tate J.J.T., Lewis V., Archer T., et al. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol. 15:1989;139-141.
12. Mustonen P., Farin P., Kosunen O. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Ann Chir Gynecol. 79:1990;15-18.
13. de Freitas R. Jr, Costa M.V., Schneider S.V., et al. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph nodes metastases in breast cancer. Eur J Surg Oncol. 17:1991;240-244.
14. Kuerer H.M., Newman L.A., Fornage B.D., et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 5:1998;673-680.
15. Cady B., Stone M.D., Schuler J.G., et al. The new era in breast cancer invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening . Arch Surg. 131:1996;301-308.
16. Haagensen C. Diseases of the Breast. 3rd ed. 1986;WB Saunders, Philadelphia.
17. Buzdar A.U., Singletary S.E., Theriault R.L., et al. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol. 17:1999;3412-3417.
18. Mansour E.G., Gray R., Shatile A.H., et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer an intergroup study . NEJM. 320:1989;485-490.
19. Fisher B., Redmond C., Dimitrov N.V., et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. NEJM. 320:1989;473-478.
20. Veronesi U., Saccozzi R., Del Vecchio M., et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. NEJM. 305:1981;6-11.
21. Danforth D.N., Findlay P.A., McDonald H.D., et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol. 4:1986;655-662.
22. Nemoto T., Natarajan N., Bedwani R., et al. Breast cancer in the medial half results of the 1978 national survey of the American College of Surgeons . Cancer. 51:1983;1333-1338.
23. Fisher B., Slack N., Bross I. Cancer of the breast size of neoplasm and prognosis . Cancer. 24:1969;1071-1080.
24. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and the limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet. 152:1981;763-772.
25. Schottenfeld D., Nash A., Robbins G., Beattie E.J. Jr. Ten-year results of the treatment of primary operable breast carcinoma. Cancer. 38:1976;1001-1007.
26. Fornage B.D., Samuels B.I., Paulus D.D., et al. The use of sonography in the evaluation of the response of locally advanced breast carcinoma to preoperative chemotherapy. J Ultrasound Med. 9:1990;23. Abstract.
27. Vassallo P., Wernecke K., Roos N., Peters P.E. Differentiation of benign from malignant superficial lymphadenectomy the role of high resolution US . Radiology. 183:1992;215-220.
28. Fornage B.D. Ultrasound of the breast. Ultrasound Quart. 11:1993;1-39.
29. Fornage BD. Role of sonography in patients with breast cancer. In: Singletary, SE, ed. Breast Cancer. New York: Springer-Verlag; 1998:18-52.
30. Pamilo M., Soiva M., Lavast E.M. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med. 8:1989;115-120.
31. Bonnema J., van Geel A.N., van Ooijen B., et al. Ultrasound-guided aspiration biopsy for detection of non-palpable axillary node metastases in breast cancer patients new diagnostic method . World J Surg. 21:1997;270-274.
32. Guiliano A.E., Dale P.S., Turner R.R., et al. Improved axillary staging of breast cancer staging with sentinel lymphadenectomy. Ann Surg. 222:1995;394-401.
33. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet. 349:1997;1864-1867.
34. Albertini J.J., Lyman G.H., Cos C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 276:1996;1818-1822.
35. Osborne M.P., Payne J.H., Richardson V.J., et al. The preoperative detection of axillary lymph node metastases in breast cancer by isotopic imaging. Br J Surg. 70:1983;141-144.
36. McClean R.G., Ege G.N. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med. 27:1986;1116-1124.
37. Tjandra J.J., Sacks N.P.M., Thompson C.H., et al. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies a prospective study . Br J Cancer. 59:1989;296-302.
38. Nieweg O., Kim E., Wong W., et al. Positron emission with fluoro-18-deoxyglucose in the detection and staging of breast cancer. Cancer. 71:1993;3920-3925.
39. Avril N., Dose J., Janicke F., et al. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabelled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst. 88:1996;1204-1209.
40. Fisher B., Redmond C., Fisher E.R., et al. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. NEJM. 312:1985;674-681.
41. Singletary S.E. Management of the axilla in early stage breast cancer. Perry M.C. American Society of Clinical Oncology, Educational Book. 1998;132-141 American Society of Clinical Oncology, Alexandria, Va.
42. Effects of radiotherapy and surgery in early breast cancer. NEJM. 333:1995;1444-1455.
43. Sun A., Liu F.F., Pintilie M., Rawlings G. Outcome in breast cancer managed without an initial axillary lymph node dissection. Radiother Oncol. 48:1998;191-196.
44. Bruce J. Operable cancer of the breast a controlled clinical trial . Cancer. 18:1971;1443-1453.